MCB 295   Spring 2007

Feb. 1

Abby Dernburg – Academia/Govt. Lab: Assistant Prof. in Residence of Cell and Developmental Biology, UC Berkeley; Senior Scientist, Life Sciences Division, Lawrence Berkeley National Lab

Jared Young – Academia: Assistant Professor of Biology, Mills College

Feb. 8

Sean George – Biotech/Consulting: Vice President of Life Science Research, Affymetrix, previously Invitrogen and McKinsey & Company

Katie Swango – Govt. Lab: Criminalist, Dept. of Justice DNA Crime Laboratory

Feb. 15

Robert Tijan – Academia: HHMI, Professor of Biochemistry and Molecular Biology, UC Berkeley

Ken Bagchi – Government: Special Agent, Federal Bureau of Investigation

Feb. 22

Cyrus Harmon – Entrepreneurship in Biotech: Previous Founder & CEO of Neomorphic, Previous Vice President of Computational Genomics, Affymetrix.

David Duhl – Biotech: Director Cell Biology/Biochemistry and Project Leader Oncology,

Novartis, previously Chiron Corporation President: (Rik Kretzinger: Sr. Recruiter for Novartis)

March 1

Irvine Mettler – Patent Law: Senior Licensing Officer, UC Berkeley

Chris Ullsperger – Patent Law: Associate, Townsend & Townsend & Crew LLP

March 8

Jennifer Kahn – Science Journalism: Contributing Editor, Wired Magazine

Howard Schachman –Public Policy: Professor of Biochemistry and Molecular Biology, UC Berkeley, NIH

March 15

Michael Dybbs – Consulting: Boston Consulting Group

Fyodor Urnov – Biotech: Scientist, Sangamo Biosciences, Inc.

March 22

Kristin Cobb – Science Writing: Clinical Assistant Professor, Dept. of Health Research, and Policy, Stanford University

Mike Eisen – Entrepreneurship in Science Journals/Govt. Lab/Academia: PLoS Co-founder; Scientist, Life Sciences Division, Lawrence Berkeley National Lab; Adjunct Assistant Professor of Genetics and Development, UC Berkeley

March 29: No Class; Spring Break

April 5

Ellen Filvaroff – Biotech: Senior Scientist of Molecular Oncology, Genentech

April 12

Bob Saul – Entrepreneurship in Biotech: founder and president, Polymorphic DNA Technologies, Inc., previously founder and president, Operon Technologies, Inc.

Robert Kuhn – Business Strategy in Biotech: Chief Technical Officer, Aerovance Inc.

April 19

To be announced

April 26

To be announced